ANEUROTECH is developing its late stage Phase III drug ANT01 in Partial Responsive Depression (PRD). ANT01 is an once daily, orally-administered small molecule to attack Subjective Cognitive Decline and Potentiate Initial Antidepressant Therapies.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Alkerstraat 30a, Alken,limburg 3570,belgium
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://aneurotech.com
- Keywords
- Alken.
- HQ
- Alken, Limburg
Aneurotech Questions
Aneurotech's website is https://aneurotech.com
Aneurotech's LinkedIn profile is https://be.linkedin.com/company/aneurotech-corp
Aneurotech has
4 employees.
View email and phone details for 4
employees at Aneurotech.
Aneurotech's industry is
Research Services
Aneurotech's top competitors are
Switchkine,
Medows Sàrl,
Biocartis,
Paire,
Smile Invest,
Anima Research,
Kois,
Glycotreat,
Mediware A.s.,
Diagnose.me.
Aneurotech's categories are Research Services
Aneurotech's founding year is 2022
